Cargando…

Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury

We report here neuroprotective and anti-inflammatory effects of a flavonoid-enriched fraction isolated from the peel of Northern Spy apples (AF4) in a mouse of model of hypoxic-ischemic (HI) brain damage. Oral administration of AF4 (50 mg/kg, once daily for 3 days) prior to 50 min of HI completely p...

Descripción completa

Detalles Bibliográficos
Autores principales: Keddy, Paul G. W., Dunlop, Kate, Warford, Jordan, Samson, Michel L., Jones, Quinton R. D., Rupasinghe, H. P. Vasantha, Robertson, George S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520852/
https://www.ncbi.nlm.nih.gov/pubmed/23251498
http://dx.doi.org/10.1371/journal.pone.0051324
_version_ 1782252846079541248
author Keddy, Paul G. W.
Dunlop, Kate
Warford, Jordan
Samson, Michel L.
Jones, Quinton R. D.
Rupasinghe, H. P. Vasantha
Robertson, George S.
author_facet Keddy, Paul G. W.
Dunlop, Kate
Warford, Jordan
Samson, Michel L.
Jones, Quinton R. D.
Rupasinghe, H. P. Vasantha
Robertson, George S.
author_sort Keddy, Paul G. W.
collection PubMed
description We report here neuroprotective and anti-inflammatory effects of a flavonoid-enriched fraction isolated from the peel of Northern Spy apples (AF4) in a mouse of model of hypoxic-ischemic (HI) brain damage. Oral administration of AF4 (50 mg/kg, once daily for 3 days) prior to 50 min of HI completely prevented motor performance deficits assessed 14 days later that were associated with marked reductions in neuronal cell loss in the dorsal hippocampus and striatum. Pre-treatment with AF4 (5, 10, 25 or 50 mg/kg, p.o.; once daily for 3 days) produced a dose-dependent reduction in HI-induced hippocampal and striatal neuron cell loss, with 25 mg/kg being the lowest dose that achieved maximal neuroprotection. Comparison of the effects of 1, 3 or 7 doses of AF4 (25 mg/kg; p.o.) prior to HI revealed that at least 3 doses of AF4 were required before HI to reduce neuronal cell loss in both the dorsal hippocampus and striatum. Quantitative RT-PCR measurements revealed that the neuroprotective effects of AF4 (25 mg/kg; p.o.; once daily for 3 days) in the dorsal hippocampus were associated with a suppression of HI-induced increases in the expression of IL-1β, TNF-α and IL-6. AF4 pre-treatment enhanced mRNA levels for pro-survival proteins such as X-linked inhibitor of apoptosis and erythropoietin following HI in the dorsal hippocampus and striatum, respectively. Primary cultures of mouse cortical neurons incubated with AF4 (1 µg/ml), but not the same concentrations of either quercetin or quercetin-3-O-glucose or its metabolites, were resistant to cell death induced by oxygen glucose deprivation. These findings suggest that the inhibition of HI-induced brain injury produced by AF4 likely involves a transcriptional mechanism resulting from the co-operative actions of various phenolics in this fraction which not only reduce the expression of pro-inflammatory mediators but also enhance pro-survival gene signalling.
format Online
Article
Text
id pubmed-3520852
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35208522012-12-18 Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury Keddy, Paul G. W. Dunlop, Kate Warford, Jordan Samson, Michel L. Jones, Quinton R. D. Rupasinghe, H. P. Vasantha Robertson, George S. PLoS One Research Article We report here neuroprotective and anti-inflammatory effects of a flavonoid-enriched fraction isolated from the peel of Northern Spy apples (AF4) in a mouse of model of hypoxic-ischemic (HI) brain damage. Oral administration of AF4 (50 mg/kg, once daily for 3 days) prior to 50 min of HI completely prevented motor performance deficits assessed 14 days later that were associated with marked reductions in neuronal cell loss in the dorsal hippocampus and striatum. Pre-treatment with AF4 (5, 10, 25 or 50 mg/kg, p.o.; once daily for 3 days) produced a dose-dependent reduction in HI-induced hippocampal and striatal neuron cell loss, with 25 mg/kg being the lowest dose that achieved maximal neuroprotection. Comparison of the effects of 1, 3 or 7 doses of AF4 (25 mg/kg; p.o.) prior to HI revealed that at least 3 doses of AF4 were required before HI to reduce neuronal cell loss in both the dorsal hippocampus and striatum. Quantitative RT-PCR measurements revealed that the neuroprotective effects of AF4 (25 mg/kg; p.o.; once daily for 3 days) in the dorsal hippocampus were associated with a suppression of HI-induced increases in the expression of IL-1β, TNF-α and IL-6. AF4 pre-treatment enhanced mRNA levels for pro-survival proteins such as X-linked inhibitor of apoptosis and erythropoietin following HI in the dorsal hippocampus and striatum, respectively. Primary cultures of mouse cortical neurons incubated with AF4 (1 µg/ml), but not the same concentrations of either quercetin or quercetin-3-O-glucose or its metabolites, were resistant to cell death induced by oxygen glucose deprivation. These findings suggest that the inhibition of HI-induced brain injury produced by AF4 likely involves a transcriptional mechanism resulting from the co-operative actions of various phenolics in this fraction which not only reduce the expression of pro-inflammatory mediators but also enhance pro-survival gene signalling. Public Library of Science 2012-12-12 /pmc/articles/PMC3520852/ /pubmed/23251498 http://dx.doi.org/10.1371/journal.pone.0051324 Text en © 2012 Keddy et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Keddy, Paul G. W.
Dunlop, Kate
Warford, Jordan
Samson, Michel L.
Jones, Quinton R. D.
Rupasinghe, H. P. Vasantha
Robertson, George S.
Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury
title Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury
title_full Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury
title_fullStr Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury
title_full_unstemmed Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury
title_short Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury
title_sort neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction af4 in a mouse model of hypoxic-ischemic brain injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520852/
https://www.ncbi.nlm.nih.gov/pubmed/23251498
http://dx.doi.org/10.1371/journal.pone.0051324
work_keys_str_mv AT keddypaulgw neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury
AT dunlopkate neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury
AT warfordjordan neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury
AT samsonmichell neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury
AT jonesquintonrd neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury
AT rupasinghehpvasantha neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury
AT robertsongeorges neuroprotectiveandantiinflammatoryeffectsoftheflavonoidenrichedfractionaf4inamousemodelofhypoxicischemicbraininjury